Please login to the form below

Not currently logged in

Spectrum Thea signs sales force agreement in UK

North 51 will develop iPad app to support order taking

Ophthalmology specialist Spectrum Thea has entered a contract sales force agreement with the resourcing division of North 51 as part of expansion plans in the UK.

North 51 will offer a full range of contract team solutions to Spectrum Thea, a joint venture between Laboratoires Thea and the UK based Spectrum.

The venture's eye care products include Blephagel for eye hygiene and Hyabak for dry eyes.

As part of the project, North 51 will make use of new digital technologies by developing an iPad application to support order taking.

“The additional team selling into pharmacy is an exciting development,” said Philip Lewis Williams, managing director of Spectrum Thea, “as we are strengthening our over-the-counter ophthalmic brands such as Otrivine Antistine.”

He added: “North 51 quickly understood our requirements and has been able to complement a tailored and professional contract team with innovative supporting technology from their digital division.”

Paul Dermody, managing director of North 51, said: “Our focus will be on providing a range of flexible solutions as the partnership develops and we hope to play a part in Spectrum Thea's ongoing success.”

24th May 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...